Lv4
729 积分 2023-07-13 加入
A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice
3天前
已完结
Whole‐brain mapping of amylin‐induced neuronal activity in receptor activity–modifying protein 1/3 knockout mice
13天前
已完结
Systemic and Central Amylin, Amylin Receptor Signaling, and Their Physiological and Pathophysiological Roles in Metabolism
13天前
已完结
Weight management treatment in obesity
13天前
已完结
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
15天前
已完结
Human Amylin: From Pathology to Physiology and Pharmacology
15天前
已完结
Allosteric inhibition of the PCSK9–LDLR interaction: structural insights for small molecule design
15天前
已完结
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis
18天前
已关闭
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
18天前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
22天前
已完结
皖公网安备34019202002308
